219 related articles for article (PubMed ID: 27287367)
1. Evaluation of bisbenzamidines as inhibitors for matriptase-2.
Beckmann AM; Gilberg E; Gattner S; Huang TL; Vanden Eynde JJ; Mayence A; Bajorath J; Stirnberg M; Gütschow M
Bioorg Med Chem Lett; 2016 Aug; 26(15):3741-5. PubMed ID: 27287367
[TBL] [Abstract][Full Text] [Related]
2. Active site mapping of trypsin, thrombin and matriptase-2 by sulfamoyl benzamidines.
Dosa S; Stirnberg M; Lülsdorff V; Häußler D; Maurer E; Gütschow M
Bioorg Med Chem; 2012 Nov; 20(21):6489-505. PubMed ID: 23026080
[TBL] [Abstract][Full Text] [Related]
3. Structure-based approach for the discovery of bis-benzamidines as novel inhibitors of matriptase.
Enyedy IJ; Lee SL; Kuo AH; Dickson RB; Lin CY; Wang S
J Med Chem; 2001 Apr; 44(9):1349-55. PubMed ID: 11311057
[TBL] [Abstract][Full Text] [Related]
4. A Bisbenzamidine Phosphonate as a Janus-faced Inhibitor for Trypsin-like Serine Proteases.
Häußler D; Scheidt T; Stirnberg M; Steinmetzer T; Gütschow M
ChemMedChem; 2015 Oct; 10(10):1641-6. PubMed ID: 26306030
[TBL] [Abstract][Full Text] [Related]
5. Changing the selectivity profile - from substrate analog inhibitors of thrombin and factor Xa to potent matriptase inhibitors.
Maiwald A; Hammami M; Wagner S; Heine A; Klebe G; Steinmetzer T
J Enzyme Inhib Med Chem; 2016; 31(sup1):89-97. PubMed ID: 27168215
[TBL] [Abstract][Full Text] [Related]
6. Design and chemical syntheses of potent matriptase-2 inhibitors based on trypsin inhibitor SFTI-1 isolated from sunflower seeds.
Gitlin-Domagalska A; Dębowski D; Łęgowska A; Stirnberg M; Okońska J; Gütschow M; Rolka K
Biopolymers; 2017 Nov; 108(6):. PubMed ID: 28555756
[TBL] [Abstract][Full Text] [Related]
7. Phosphono Bisbenzguanidines as Irreversible Dipeptidomimetic Inhibitors and Activity-Based Probes of Matriptase-2.
Häußler D; Mangold M; Furtmann N; Braune A; Blaut M; Bajorath J; Stirnberg M; Gütschow M
Chemistry; 2016 Jun; 22(25):8525-35. PubMed ID: 27214780
[TBL] [Abstract][Full Text] [Related]
8. Limiting the Number of Potential Binding Modes by Introducing Symmetry into Ligands: Structure-Based Design of Inhibitors for Trypsin-Like Serine Proteases.
Furtmann N; Häußler D; Scheidt T; Stirnberg M; Steinmetzer T; Bajorath J; Gütschow M
Chemistry; 2016 Jan; 22(2):610-25. PubMed ID: 26625703
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of neutral C-terminal residues in 3-amidinophenylalanine-derived matriptase inhibitors.
Schweinitz A; Dönnecke D; Ludwig A; Steinmetzer P; Schulze A; Kotthaus J; Wein S; Clement B; Steinmetzer T
Bioorg Med Chem Lett; 2009 Apr; 19(7):1960-5. PubMed ID: 19250826
[TBL] [Abstract][Full Text] [Related]
10. Identification of the first low-molecular-weight inhibitors of matriptase-2.
Sisay MT; Steinmetzer T; Stirnberg M; Maurer E; Hammami M; Bajorath J; Gütschow M
J Med Chem; 2010 Aug; 53(15):5523-35. PubMed ID: 20684597
[TBL] [Abstract][Full Text] [Related]
11. Recent progress on inhibitors of the type II transmembrane serine proteases, hepsin, matriptase and matriptase-2.
Damalanka VC; Janetka JW
Future Med Chem; 2019 Apr; 11(7):743-769. PubMed ID: 30945556
[TBL] [Abstract][Full Text] [Related]
12. Amido-(propyl and allyl)-hydroxybenzamidines: development of achiral inhibitors of factor Xa.
Gong Y; Pauls HW; Spada AP; Czekaj M; Liang G; Chu V; Colussi DJ; Brown KD; Gao J
Bioorg Med Chem Lett; 2000 Feb; 10(3):217-21. PubMed ID: 10698439
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological activity of novel rigid amidino-phenylalanine derivatives as inhibitors of thrombin.
Mack H; Pfeiffer T; Hornberger W; Böhm HJ; Höffken HW
J Enzyme Inhib; 1995; 9(1):73-86. PubMed ID: 8568568
[TBL] [Abstract][Full Text] [Related]
14. Improving the selectivity of 3-amidinophenylalanine-derived matriptase inhibitors.
Pilgram O; Keils A; Benary GE; Müller J; Merkl S; Ngaha S; Huber S; Chevillard F; Harbig A; Magdolen V; Heine A; Böttcher-Friebertshäuser E; Steinmetzer T
Eur J Med Chem; 2022 Aug; 238():114437. PubMed ID: 35635944
[TBL] [Abstract][Full Text] [Related]
15. Design of benzamidine-type inhibitors of factor Xa.
Gabriel B; Stubbs MT; Bergner A; Hauptmann J; Bode W; Stürzebecher J; Moroder L
J Med Chem; 1998 Oct; 41(22):4240-50. PubMed ID: 9784099
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core.
Fevig JM; Pinto DJ; Han Q; Quan ML; Pruitt JR; Jacobson IC; Galemmo RA; Wang S; Orwat MJ; Bostrom LL; Knabb RM; Wong PC; Lam PYS ; Wexler RR
Bioorg Med Chem Lett; 2001 Mar; 11(5):641-5. PubMed ID: 11266160
[TBL] [Abstract][Full Text] [Related]
17. Modification of the N-terminal sulfonyl residue in 3-amidinophenylalanine-based matriptase inhibitors.
Steinmetzer T; Dönnecke D; Korsonewski M; Neuwirth C; Steinmetzer P; Schulze A; Saupe SM; Schweinitz A
Bioorg Med Chem Lett; 2009 Jan; 19(1):67-73. PubMed ID: 19036586
[TBL] [Abstract][Full Text] [Related]
18. From natural products to achiral drug prototypes: potent thrombin inhibitors based on P2/P3 dihydropyrid-2-one core motifs.
Hanessian S; Therrien E; Zhang J; Otterlo Wv; Xue Y; Gustafsson D; Nilsson I; Fjellström O
Bioorg Med Chem Lett; 2009 Sep; 19(18):5429-32. PubMed ID: 19674897
[TBL] [Abstract][Full Text] [Related]
19. α-Ketobenzothiazole Serine Protease Inhibitors of Aberrant HGF/c-MET and MSP/RON Kinase Pathway Signaling in Cancer.
Han Z; Harris PK; Karmakar P; Kim T; Owusu BY; Wildman SA; Klampfer L; Janetka JW
ChemMedChem; 2016 Mar; 11(6):585-99. PubMed ID: 26889658
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and SAR of monobenzamidines and aminoisoquinolines as factor Xa inhibitors.
Zhang P; Zuckett JF; Woolfrey J; Tran K; Huang B; Wong P; Sinha U; Park G; Reed A; Malinowski J; Hollenbach S; Scarborough RM; Zhu BY
Bioorg Med Chem Lett; 2002 Jun; 12(12):1657-61. PubMed ID: 12039584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
